-
1 Comment
Themis Medicare Limited is currently in a long term uptrend where the price is trading 82.8% above its 200 day moving average.
From a valuation standpoint, the stock is 72.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Themis Medicare Limited's total revenue rose by 21.8% to $655M since the same quarter in the previous year.
Its net income has increased by 10.3% to $118M since the same quarter in the previous year.
Finally, its free cash flow grew by 487.1% to $313M since the same quarter in the previous year.
Based on the above factors, Themis Medicare Limited gets an overall score of 5/5.
Exchange | NSE |
---|---|
CurrencyCode | INR |
ISIN | INE083B01024 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Beta | -0.07 |
---|---|
PE Ratio | 27.09 |
Target Price | None |
Dividend Yield | 0.4% |
Market Cap | 12B |
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for THEMISMED.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025